Mandate

Vinge has advised Litorina V and the Bergfalk group

June 15, 2018 Banking and Finance

Vinge has advised Litorina V and the Bergfalk group in connection with the acquisition of Johan i Hallen i Göteborg AB, a leading Swedish distributor within fresh food with focus on meat.

The company has a turnover of over SEK 640 million and offers its products in Sweden. The company's former main owners and management will remain as significant owners going forward. Through the transaction a partnership is established between the Bergfalk-group and Johan i Hallen creating one of the leading specialist distributors within fresh food with focus on meat, fish and shellfish.

Vinge’s team consisted of partner Jonas Johansson together with the associates Carl Sander and Martin Cronsioe (M&A), Sara Strandberg and Sophia Holm (employment), Kristoffer Larson (real estate), Arvid Axelryd (IP) and Johan Cederblad (environment. Johan Wahlbom provided competition law advice. Partner Louise Brorsson Salomon and associate Sebastian Frisk assisted with the financing.
 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025